MOESM2 of Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara

Authors :: Mahamadou Thera
Drissa Coulibaly
Abdoulaye Kone
Guindo, Ando
Traore, Karim
Abdourhamane Sall
Diarra, Issa
Modibo Daou
Idrissa Traore
Tolo, Youssouf
Sissoko, Mady
Amadou Niangaly
Arama, Charles
Mounirou Baby
Bourema Kouriba
Mahamadou Sissoko
Issaka Sagara
Ousmane Toure
Amagana Dolo
Dapa Diallo
Remarque, Edmond
Chilengi, Roma
Ramadhani Noor
Sesay, Sanie
Thomas, Alan
Kocken, Clemens
Faber, Bart
Egeruan Imoukhuede
Leroy, Odile
Ogobara Doumbo
Publication Year :: 2016
Publisher :: Figshare, 2016.
Abstract: Additional file 2. Solicited adverse event intensity scale.

Full Text Access

Tools